Search results
Results from the WOW.Com Content Network
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
Despite operating for nearly two decades without profit, 23andMe went public in 2021 and reached a $6 billion valuation. The company's stocks were priced at $11.13 a share, but they've fallen ...
As for Wojcicki, 23andMe has garnered takeover interest from a small New York–based DNA testing startup called Nucleus, but Wojcicki has maintained she is not open to outside offers.
23andMe went public in June 2021 at $11.13 a share, marking a victory for the company after struggling with sales. Before going public, ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
Meanwhile, 23andMe’s drug research (a notoriously expensive and often fruitless business) has also failed to generate significant revenue. The company is now worth less than $200 million — a ...
One thing to note is that 23andMe reports “do not diagnose any health conditions or provide medical advice,” according to the brand’s website. Total Health is a new foray for 23andme, but ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!